1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

MPN - 318

Characterization of Symptoms After Immediate Transition From Ruxolitinib to Momelotinib in Patients With Myelofibrosis: Post-Hoc Analyses of the Phase 3 SIMPLIFY-1 and SIMPLIFY-2 Trials

Preview of Characterization of Symptoms After Immediate Transition From Ruxolitinib to Momelotinib in Patients With Myelofibrosis: Post-Hoc Analyses of the Phase 3 SIMPLIFY-1 and SIMPLIFY-2 Trials

View Poster Contact Presenter

Poster Presenter

Pankit J Vachhani

Authors

Pankit J Vachhani

Part of Topic

Myeloproliferative Neoplasms (MPN)

Characterization of symptoms after immediate transition from ruxolitinib to momelotinib in patients with myelofibrosis: post hoc analyses of the phase 3 SIMPLIFY-1 and SIMPLIFY-2 trials

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.